Profit incentivizes innovation and helps fund research and development.
September 17, 2018 10:43AM
August 28, 2018 1:00AM
July 17, 2003 2:00AM
Before breaking for the summer, the House of Commons Standing Committee on Industry, Science, and Technology considered weakening the patent regulations that support Canadas pharmaceutical market. Now, prompted by public-sector unions, the Competition Bureau will look at whether pharmaceutical patents are anti-competitive. These investigations have only one result: to harm international investors confidence in Canadas will to protect intellectual property. Furthermore, history suggests that if they succeed in weakening patents, drug costs are unlikely to come down.